Diploma thesis was aimed to deal with evaluation of microrheology method in the research of biopolymer-protein. Used biopolymer was sodium hyaluronate and proteins were trypsin and chymotrypsin. For measuring of microrheology were used particles with different radius (0,5 m and 1 m). It was found, that both substances have viscous charakter. Passive microrheology is suitable for measuring the viscoelastic properties of biopolymers.

No description available.

The mode of action of known natu,ral and syritheti􀀔 inhibitors of the serine _ protease trypsin was studied using struc􀀝e-based drug design: Three groups of putative . . inhibitors were examined. Group I inhibitors consist of molecules designed to incorporate the binding properties of a natural inhibit􀀭r. Group 11 inhibitors wern . . . constructed from a combination of a· hydrophobic tetrapeptide and a hydrophilic di peptide, and Group III were cyclic phenylthiohydru1toin deriv􀀼tives: As a result of the study of the interactioris between certain residri􀁈􀁉 or.features of the inhibitor m􀀅lecule, such as hydrophobic appendages . or cyclic conformation, .. and specific .· binding sites . on the surface of the enzyme, the_ ma1n features of binding of the serine proteases were delineated Relative binding eilergi􀁟s obtained fr􀁠m moJecular modeling and computational chemistry show that _many of th_e de􀁧igned 1nhibitors exhibit fav9rable . binding. One lead compound, a phenylthiohydantoin- arginine • was shown 􀁲y fluoresc􀁴nt _­ assay.to inhibit Bovine trypsin.

Ho, Sai Man. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2007. / Includes bibliographical references (leaves 144-164). / Abstracts in English and Chinese. / TABLE OF CONTENTS --- p.ii / ABSTRACT --- p.xii / 撮要 --- p.xv / LIST OF ABBREIVIATIONS --- p.xvi / LIST OF TABLES --- p.xvii / LIST OF FIGURES --- p.xix / Chapter Chapter 1 --- General Introduction / Chapter 1.1 --- Overview of lectins --- p.1 / Chapter 1.1.1 --- History of lectins --- p.1 / Chapter 1.1.2 --- Definitions of lectins --- p.2 / Chapter 1.1.3 --- Classification and nomenclature of lectins based on structure --- p.2 / Chapter 1.1.4 --- Classification and nomenclature of lectins based on carbohydrate-bindingspecificity --- p.4 / Chapter 1.1.5 --- Structure of plant lectins --- p.4 / Chapter 1.1.6 --- Biological function of plant lectins --- p.5 / Chapter 1.1.6.1 --- Anti-viral activity of plant lectiins --- p.5 / Chapter 1.1.6.2 --- Lectins as plant defense proteins --- p.6 / Chapter 1.1.6.3 --- Insecticidal activity of plant lectins --- p.7 / Chapter 1.1.6.4 --- Anti-fungal activity of plant lectins --- p.7 / Chapter 1.1.6.5 --- Mitogenic activity of plant lectins --- p.7 / Chapter 1.1.6.6 --- Anti-tumor and anti-proliferative activity of plant lectins --- p.9 / Chapter 1.1.7 --- Background of legume lectins --- p.11 / Chapter 1.1.7.1 --- Structure of legume lectins --- p.11 / Chapter 1.1.7.2 --- Functions and activities of legume lectins --- p.12 / Chapter 1.2 --- Overview of serine protease inhibitors in plants --- p.14 / Chapter 1.2.1 --- Classification of serine protease inhibitor --- p.15 / Chapter 1.2.2 --- The main functions of plant serine protease inhibitors --- p.17 / Chapter 1.2.3 --- Commercial application of serine protease inhibirtors --- p.19 / Chapter 1.2.3.1 --- Medical application --- p.19 / Chapter 1.2.3.2 --- Transgenic application in agriculture --- p.22 / Chapter 1.3 --- Overview of Pathogenesis-related proteins in plants --- p.25 / Chapter 1.3.1 --- Overview of PR-5 family Thaumatin-like proteins (TLPs) --- p.27 / Chapter 1.3.1.1 --- Structural similarities among TLPs --- p.28 / Chapter 1.3.1.2 --- Antifungal activity of TLP --- p.31 / Chapter 1.3.2 --- Overview of Chinase-like proteins (CLPs) --- p.33 / Chapter 1.3.2.1 --- Classification of chitinase --- p.34 / Chapter 1.3.2.1.1 --- On the basis of amino acid sequence of glycosyl hydrolase --- p.34 / Chapter 1.3.2.1.2 --- On the basis of amino acid sequence of plant chitinase --- p.35 / Chapter 1.3.2.2 --- Antifungal activity of CLP --- p.36 / Chapter 1.3.3 --- Anti-freeze property of PR proteins --- p.38 / Chapter 1.3.4 --- Application of PR proteins in agriculture --- p.40 / Chapter 1.4 --- Rationale of the present study --- p.42 / Chapter Chapter 2 --- Materials and Methods / Chapter 2.1 --- Materials --- p.43 / Chapter 2.2 --- Preparation of crude extract --- p.44 / Chapter 2.2.1 --- Hokkaido large black soybean --- p.44 / Chapter 2.2.2 --- Emperor banana --- p.45 / Chapter 2.3 --- Purification --- p.45 / Chapter 2.4 --- Chromatography --- p.46 / Chapter 2.4.1 --- DEAE-cellulose chromatography --- p.46 / Chapter 2.4.2 --- Affi-gel Blue gel --- p.47 / Chapter 2.4.3 --- SP-Sepharse --- p.48 / Chapter 2.4.4 --- Mono Q HR 5/5 and Mono S HR 5/5 --- p.49 / Chapter 2.4.5 --- Superdex 75 and superdex 200 --- p.50 / Chapter 2.5 --- Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) --- p.50 / Chapter 2.6 --- Protein concentration determination --- p.54 / Chapter 2.7 --- Preparation of rabbit reticulocyte lysate --- p.54 / Chapter 2.8 --- Determination of N-terminal amino acid sequence --- p.56 / Chapter 2.9 --- Assay of inhibition of hemagglutinating activity by different carbohydrates --- p.56 / Chapter 2.10 --- Thermal stability determination assays --- p.57 / Chapter 2.10.1 --- Stability at various temperatures --- p.57 / Chapter 2.10.2 --- Stability at 100°C --- p.57 / Chapter 2.11 --- Assay of pH dependence of hemagglutinating activity --- p.58 / Chapter 2.12 --- Assay of ion dependence of hemagglutinating activity --- p.58 / Chapter 2.13 --- Assay of antifungal activity --- p.58 / Chapter 2.14 --- Assay of trypsin inhibitory activity --- p.60 / Chapter 2.15 --- Assay of antibacterial activity --- p.61 / Chapter 2.16 --- Assay for cytotoxic activity on cancer cell lines --- p.61 / Chapter 2.17 --- Assay for HIV-1 reverse transcriptase (RT) inhibitory activity --- p.62 / Chapter 2.18 --- Assay of mitogenic activity --- p.63 / Chapter Chapter 3 --- Purification and Characterization of Defense-Related Proteins from their Respective Sources / Chapter 3.1 --- Purification and Characterization of a Lectin from the Seeds of Hokkaido large black soybean / Chapter 3.1.1 --- Introduction --- p.65 / Chapter 3.1.2 --- Results --- p.66 / Chapter 3.1.3 --- Purification --- p.68 / Chapter 3.1.3.1 --- Affinity chromatography on Affi-gel Blue gel --- p.69 / Chapter 3.1.3.2 --- Anion-exchange chromatography on DEAE-cellulose --- p.70 / Chapter 3.1.3.3 --- Anion-exchange chromatography on Mono Q column --- p.71 / Chapter 3.1.3.4 --- Gel filtration on Superdex 200 column --- p.72 / Chapter 3.1.3.5 --- Hemagglutinating activity at each purification step --- p.73 / Chapter 3.1.4 --- Characterization of Lectin --- p.74 / Chapter 3.1.4.1 --- Molecular mass determination --- p.74 / Chapter 3.1.4.2 --- N-terminal amino acid sequencing --- p.76 / Chapter 3.1.4.3 --- Assay of inhibition of hemagglutinating activity by different carbohydrates --- p.77 / Chapter 3.1.4.4 --- Thermal stability --- p.78 / Chapter 3.1.4.5 --- Assay of pH dependence of hemagglutinating activity --- p.80 / Chapter 3.1.4.6 --- Assay of ion dependence of hemagglutinating activity --- p.81 / Chapter 3.1.4.7 --- Assay for HIV-1 reverse transcriptase (RT) inhibitory activity --- p.82 / Chapter 3.1.4.8 --- Assay of mitogenic activity --- p.83 / Chapter 3.1.4.9 --- Assay of antibacterial activity --- p.84 / Chapter 3.1.5 --- Discussion --- p.86 / Chapter 3.2 --- Purification and Characterization of a Trypsin inhibitor from the Seeds of Hokkaido large black soybean / Chapter 3.2.1 --- Introduction --- p.93 / Chapter 3.2.2 --- Results --- p.94 / Chapter 3.2.3 --- Purification --- p.95 / Chapter 3.2.3.1 --- Anion-exchange chromatography on Mono Q column --- p.96 / Chapter 3.2.3.2 --- Gel filtration on Superdex 75 column --- p.98 / Chapter 3.2.3.3 --- Trypsin inhibitory activity at each purification step --- p.99 / Chapter 3.2.4 --- Characterization of trypsin inhibitory --- p.100 / Chapter 3.2.4.1 --- Molecular mass determination --- p.100 / Chapter 3.2.4.2 --- N-terminal amino acid sequencing --- p.102 / Chapter 3.2.4.3 --- Assay for HIV-1 reverse transcriptase (RT) inhibitory activity --- p.103 / Chapter 3.2.4.4 --- Antiproliferative effect on MCF-7 and Hep G2 cells --- p.104 / Chapter 3.2.4.5 --- pH and thermal stability --- p.105 / Chapter 3.2.5 --- Discussion --- p.106 / Chapter 3.3 --- Purification and Characterization of a Thaumatin-like protein and Chitinase-like protein from Emperor Banana / Chapter 3.3.1 --- Introduction --- p.108 / Chapter 3.3.2 --- Results --- p.109 / Chapter 3.3.3 --- Purification --- p.111 / Chapter 3.3.3.1 --- Affinity chromatography on Affi-gel Blue gel --- p.112 / Chapter 3.3.3.2 --- Cation exchange chromatography on Mono S column --- p.113 / Chapter 3.3.3.3 --- Gel filtration on Superdex 75 column --- p.114 / Chapter 3.3.3.3.1 --- Fraction MS 2 --- p.114 / Chapter 3.3.3.3.2 --- Fraction MS 4 --- p.115 / Chapter 3.3.3.3.3 --- Fraction MS 5 --- p.118 / Chapter 3.3.4 --- Characterization of the thaumatin-like protein --- p.121 / Chapter 3.3.4.1 --- N-terminal amino acid sequence determination --- p.121 / Chapter 3.3.4.2 --- Assay for antifungal activity --- p.122 / Chapter 3.3.4.3 --- Thermal stability --- p.124 / Chapter 3.3.4.4 --- pH stability --- p.125 / Chapter 3.3.4.5 --- Resistance to trypsin digestion --- p.125 / Chapter 3.3.4.6 --- Anti-HIV-1 reverse transcriptase activity --- p.126 / Chapter 3.3.4.7 --- Discussion --- p.127 / Chapter 3.3.5 --- Characterization of the two chitinase-like protein --- p.131 / Chapter 3.3.5.1 --- N-terminal amino acid sequence determination --- p.131 / Chapter 3.3.5.1.1 --- Emperor banana MS2 CLP --- p.131 / Chapter 3.3.5.1.2 --- Emperor banana MS4 CLP --- p.132 / Chapter 3.3.5.2 --- Assay for antifungal activity --- p.133 / Chapter 3.3.5.3 --- Discussion --- p.136 / Chapter Chapter 4 --- general discussion --- p.138 / References --- p.144

La Fibrose Pulmonaire Idiopathique (FPI) est une pathologie pulmonaire chronique, progressive, irréversible et mortelle, dont les thérapeutiques sont insuffisantes à ce jour. L'activation de la cascade de la coagulation et des protéases à sérine, délétère dans la progression des maladies pulmonaires chroniques, est une caractéristique de la pathologie. Récemment, un lien a été démontré entre Protease-Activated Receptor-2 (PAR-2), un récepteur cellulaire ubiquitaire, et la progression de la fibrose pulmonaire chez l'homme et la souris. Outre certains facteurs de la coagulation, PAR-2 semble aussi pouvoir être activé par des protéases appartenant à la famille récemment identifiée des Type II Transmembrane Serine Proteases (TTSPs), dont la matriptase et la Human Airway Trypsin-like protease (HAT). Leur rôle dans la fibrogénèse pulmonaire humaine et expérimentale est cependant encore inconnu.Nos travaux montrent pour la première fois qu'il existe une dérégulation de l'expression et de l'activité de ces protéases de la famille des TTSPs chez le patient FPI. In vitro, la matriptase induit des réponses pro-fibrosantes dans les fibroblastes pulmonaires primaires humains via l'activation de PAR-2, tandis que la HAT induit des réponses anti-fibrosantes dans ces cellules et une activation de la voie de la prostaglandine E2. Ces deux TTSPs sont ainsi différemment impliquées dans la fibrogénèse pulmonaire : in vivo, l'inhibition génétique et pharmacologique de la matriptase atténue la fibrose dans le modèle murin de fibrose pulmonaire induite par la bléomycine, et des résultats similaires sont observés suite à la surexpression de la HAT médiée par adénovirus dans ce modèle animal. L'ensemble des résultats obtenus dans ce travail de thèse permet de documenter l'implication de deux protéases à sérine, la matriptase et la HAT, dans la pathogénèse de la FPI et de définir des axes de recherche thérapeutique potentiels / Idiopathie Pulmonary Fibrosis (IPF) is a chronic, progressive, irreversible and mortal disease. Therapeutics options that improve the clinical outcome of IPF are limited. Coagulation proteinases and coagulation signaling deregulation, which influences several key inflammatory and fibroproliferative responses, is essential in IPF. Recently, Protease-Activated Receptor-2 (PAR-2) was shown to be involved in pulmonary fibrogenesis, both in Human and in mice. In addition to coagulation factors, PAR-2 can be activated by serine proteases of the emerging Type II Transmembrane Serine Proteases (TTSPs) family, including matriptase and the Human Airway Trypsin-like protease (HAT). Herein we explored the role of matriptase and HAT in the progression of human and experimental pulmonary fibrosis.Our data show that TTSPs matriptase and HAT pulmonary expression and activity are deregulated in patients with IPF. In vitro, matriptase induces PAR-2 dependent pro-fibrotic responses in primary human lung fibroblasts, whereas HAT induces anti-fibrotic effects in these cells, through the activation of prostaglandin E2 pathway. These TTSPs are differently involved in pulmonary fibrogenesis: in vivo, genetic and pharmacological inhibition of matriptase reduces fibrosis in the bleomycin induced lung fibrosis model, while an adenovirus-mediated HAT overexpression in the murine model leads also to a limited lung fibrosis. Here, we highlight the involvement of matriptase and HAT in the pathogenesis of IPF and explore potential therapeutics for lung fibrosis

No description available.

Zweitveröffentlichung / Polyelektrolytmikrokapseln (PEMC) stellen ein neuartiges System künstlicher Zellen dar. Durch Einbringen von z.B. Hämoglobin in solche PEMC können sie als  künstliche Erythrozyten den Gastransport im Organismus unterstützen bzw. übernehmen. Es muss jedoch berücksichtigt werden, dass jede Zelle des Säugtierorganismus zur Aufrechterhaltung ihrer Funktion Enzyme benötigt, die ihre Stoffwechselfunktionen katalysieren. Um sich der Lösung dieses Problems bei der Entwicklung eines künstlichen Erythrozyten schrittweise zu nähern, wurde als Modellenzym Trypsin ausgewählt. Es wurden Polyelektrolytmikrokapseln (PEMC) auf der Basis von Erythrozyten durch Selbstassemblierung von Polynatriumstyrensuphonat (PSS) und Polyallylamino-hydrochlorid (PAH) hergestellt ((PSS/PAH)2PSS), und anschliessend nach der Layer-by-Layer Methode (LbL) alternierend mit Trypsin und den Polyelektrolyten (PE) PSS, Alginat oder Dextransulphat weiterbeschichtet. Der Schichtenaufbau wurde durch Zellelektrophorese, konfokale Laserscanning-mikroskopie (CLSM), Durchflusszytometrie (FACS) und photometrische Proteinbestimmung charakterisiert und quantifiziert. Die Aktivität des an der PEMC-Membran immobilisierten Enzyms wurde untersucht und mit der Aktivität freien Trypsins verglichen. Weiterhin wurden pH-Profile von freiem Enzym mit denen des immobilisierten Trypsins verglichen. Der Schichtaufbau aus Trypsin und den unterschiedlichen Polyelektrolyten wurde anhand der Änderung der elektrophoretischen Mobilität beim Aufbringen jeder Schicht, sowie durch die Zunahme der photometrisch bestimmten Proteinmenge pro PEMC charakterisiert. Außerdem wurde Trypsin mit Fluoreszeinisothiozyanat (FITC) markiert und in den Beschichtungsserien die Zunahme der flowzytometrisch bestimmten Fluoreszenz-Intensität mit jeder aufgebrachten FITC-Trypsin Schicht beobachtet. Die Aktivität des an den PEMC immobilisierten Trypsins beträgt etwa 30% der Aktivität freien Trypsins gleicher Konzentration. Es konnte gezeigt werden, dass sich Trypsin im Rahmen eines Schichtaufbaus nach der LbL-Technologie in die Membran der verwendeten PEMC einbringen lässt. Dabei behält das Enzym einen Teil seiner Funktion. / Artificial cells are not only used to study the biological processes of living cells, they also serve as micro reactors to provide certain functions in the organism. Polyelectrolyte microcapsules (PEMC) represent a new approach to artificial cell studies. When filled with hemoglobin, PEMC are able to perform the erythrocyte gas exchange. This work shows the general possibility of integrating enzymes into the PEMC membrane. PEMC were composed using the layer-by-layer (l-b-l) technique. Glutaraldehyde stabilized human red blood cells (RBC) served as templates and were coated with five layers poly(styrene sulfonate) (PSS) and poly(allylaminehydrochloride) (PAH). After decomposition of the RBC by sodium hypochlorite, the PEMC were coated with ten layer pairs of trypsin and either PSS or alginate. The trypsin layer growth was followed performing measurements by cell electrophoresis, confocal laser scanning microscopy (CLSM), flow cytometry (FACS) and protein determination according to Lowry after each adsorption step. Results showed a continuous layer buildup for both polyelectrolytes and no desorption of trypsin. The amount of immobilized enzyme was larger for the coating series with trypsin/PSS compared to that with trypsin/alginat. This was concluded as a result of PSS/trypsin complex formation. Normalizing the enzym activity to the amount of adsorbed trypsin no significant differences between the activity of PSS-PEMC and alginate-PEMC were found. Further experiments prove that PSS inhibits the enzyme activity and alginat does not.

Blood fluke Schistosoma mansoni is one of the most important human parasites. Proteolytic system of schistosoma is crucial for parasite - host interactions. Therefore some of the proteases became potential therapeutic targets. This work is focused on not yet characterized serine protease SmSP2. SmSP2 is newly discovered protease of S. mansoni, whose biological role is unknown. This protease is highly expressed in developmental stages parasitizing humans. SmSP2 was recombinantly expressed in prokaryotic and eukaryotic expression system (E. coli a P. pastoris) and purified using chromatographic methods. Recombinant SmSP2 was used for polyclonal antibody production. Conditions for refolding were optimized. Basic biochemical properties of the protease were detected and substrate amino acid preferences for P1 - P4 sites for single aminoacids were identified using synthetic fluorogenic peptides for positional scanning substrate combinatorial library (PS-SCL). (In Czech)

Os objetivos do presente trabalho foram: i) aprimorar o procedimento alternativo de mediação por íons metálicos da alcoólise da ligação peptidil-resina com vistas à obtenção de ésteres metílicos de peptídeos protegidos (Nα-acil-peptídeo protegido-OMe) em condição reacional branda e com alta eficiência; ii) investigar a aplicabilidade do procedimento para a preparação de Nα-acil-peptídeo protegido-SR e de Nα-acil-aminoácido-OR; iii) verificar se os Nα-acil-peptídeo-OMe obtidos atuariam como doadores de acila em reações de formação de ligação peptídica catalisadas por lipases. Para tanto, na busca da melhor condição de metanólise e comparação com os procedimentos usuais de alcoólise de ligação peptidil-resina, foram usados: o fragmento 22-24 da colecistocinina-33 humana (tripeptídeo modelo), Ca2+, Zn+2, Co+2 e Cu+2 (mediadores), as resinas oxima de Kaiser (KOR), p-hidroximetilfenil acetamidometil, ácido p-hidroximetilbenzóico e álcool p-benziloxibenzil (suportes poliméricos), misturas de MeOH com DCM, DMSO, NMP, THF ou DMF (solventes) e 25, 37, 50 ou 60°C. A condição ótima encontrada [KOR, Ca+2 (1 eq./eq. de peptídeo), 50% MeOH/DMF, 50°C] foi empregada com sucesso na preparação do Nα--acil-heptapeptídeo protegido-OMe, fragmento do peptídeo quimiotático M de Vespa mandarinia. Variações dessa condição foram usadas com sucesso nas preparações dos Nα-acil-tripeptídeo protegido-S(CH2)2COOEt e Nα-acil-Ala-OR (R: Me; Bzl), pois eles foram gerados com boas qualidades e rendimentos similares ou superiores aos obtidos via procedimentos usuais. Após desproteção de cadeias laterais, os Nα-acil-tripeptídeo-OMe e Nα-acil-heptapeptídeo-OMe foram usados em reações de acoplamento com Gly-NH2 em presença de preparações lipásicas comerciais. Estes ensaios inéditos também foram bem sucedidos, pois após adequação das condições reacionais, os Nα-acil-tetrapeptídeo-NH2 e Nα-acil-octapeptídeo-NH2 foram obtidos com boas qualidades e rendimentos de 65% (1 h) e 55% (24 h), respectivamente. / The present work aimed to: i) improve the alternative procedure based on mediation by metal ions of peptide-resin linkage alcoholysis to obtain fully protected peptide methyl esters (Nα-acyl-protected peptide-OMe) under mild reaction condition and with high efficiency; ii) investigate the usefulness of the alternative procedure for preparing Nα-acyl-protected peptide-SR and Nα-acyl-amino acid-OR; iii) verify whether the resulting Nα-acyl-peptide-OMe would act as acyl donors in peptide bond formation catalyzed by lipases. Thus, in the search for the best methanolysis condition and comparison with the usual procedures for that, we used: fragment 22-24 of human cholecystokinin-33 (model tripeptide), Ca+2, Zn+2, Co+2 and Cu+2 (mediators), Kaiser oxime resin (KOR), p-hydroxymethylphenylacetamido methyl resin, p-hydroxymethylbenzoic acid resin and p-benzyloxy benzyl alcohol resin (polymeric supports), mixtures of MeOH and DCM, DMSO, NMP, THF or DMF (solvents) and 25, 37, 50 or 60°C. The optimal condition found [KOR, Ca+2 (1 eq./eq. of peptide), 50% MeOH/DMF, 50°C] was used successfully for preparing Nα-acyl-protected heptapeptide-OMe, fragment 1-7 of the chemotactic peptide M produced by Vespa mandarinia. Variations of this condition were employed successfully for preparing Nα-acyl-protected tripeptide-SR and Nα-acyl-Ala-OR (R: Me, Bzl): indeed, these compounds were obtained in good quality and with similar or superior yields than those provided by usual procedures. After side chain deprotections, the Nα-acyl-tripeptide and Nα-acyl-heptapeptide methyl esters obtained were used in coupling reactions with Gly-NH2 in the presence of commercial lipase preparations. Those pioneer reactions were also successful, since after optimizing the conditions, Nalfa-acyl-tetrapeptide-NH2 and Nα-acyl-octapeptide-NH2 were obtained in good qualities with yields of 65% (1 h) and 55% (24 h), respectively.

A nanociência e a nanotecnologia vêm abrindo inúmeros desenvolvimentos de dispositivos e sistemas em escala nanométrica, com novas organizações moleculares, propriedades e funções distintas. Nesse contexto, as nanopartículas magnéticas poliméricas são compósitos formados por materiais magnéticos com tamanhos de partículas entre 1 e 100 nm combinados com polímeros funcionais. São materiais bem conhecidos e têm sido amplamente estudados devido às suas aplicações em diversas áreas tecnológicas. Nas áreas biológica e médica, as aplicações incluem separação e imobilização de enzimas e proteínas, melhoria nas técnicas de imagem de ressonância magnética para diagnóstico e sistemas de liberação controlada de fármacos. Neste trabalho, proteínas foram imobilizadas na superfície de um biopolímero combinado com partículas superparamagnéticas de magnetita para formar o compósito magnético. Utilizou-se o biopolímero quitosana, reticulada e funcionalizada com glutaraldeído, aplicável em ensaios biológicos. Obtiveram-se 3 tipos de compósitos magnéticos, os quais foram nomeados QM1Glu, QM2NaGlu e QM3Glu. Foram caracterizados por difratometria de raios X, microscopia eletrônica de varredura, magnetometria de amostra vibrante, calorimetria exploratória diferencial, termogravimetria e espectroscopia por infravermelho. Foram avaliados quanto à imobilização das proteínas albumina de soro bovino (SAB), colágeno e tripsina. A imobilização das proteínas no biopolímero ocorreu em 30 min de incubação. O compósito magnético de quitosana não funcionalizada (QM3) também foi avaliado. Para a tripsina verificou-se que QM3 apresentou maior potencial de imobilização do que QM3Glu. Após 30 dias, QM3-Trip e QM3Glu-Trip ainda apresentavam a tripsina ativada. Foram demonstradas a atividade e a cinética enzimática da QM3Glu-trip com o substrato BApNA. / Nanoscience and nanotechnology have opened up numerous developments of devices and systems on the nanometer scale, with new molecular organization, properties and functions. In this context, the polymeric magnetic nanoparticles are composites formed by magnetic materials with a particle size between 1 and 100 nm combined with functional polymers. They are well-known and have been widely studied because of its applications in various technology areas. Applications on the biological and medical areas include separation and immobilization of enzymes and proteins, improved techniques of magnetic resonance imaging and diagnostic systems for controlled drug delivery. In this work, proteins were immobilized on the surface of a biopolymer combined with superparamagnetic particles of magnetite. The biopolymer chitosan was used, cross-linked and functionalized with glutaraldehyde, applicable to the biological assays. Three types of magnetic composites were obtained, which were called QM1Glu, QM2NaGlu and QM3Glu. They were characterized by X-ray diffraction, scanning electron microscopy, vibrating sample magnetometry, differential scanning calorimetry, thermogravimetry and infrared spectroscopy. They were evaluated concerning the immobilization of the proteins bovine serum albumin (BSA), collagen and trypsin. The study showed that the immobilization of proteins on the biopolymer occurred in 30 min of incubation. The magnetic composite of nonfunctionalized chitosan (QM3) was also evaluated. For trypsin, it was found that the immobilization potential of QM3 was higher than that observed for QM3Glu. After 30 days, the trypsin of the QM3-Trip and QM3Glu-Trip was still with activity. The activity and the enzyme kinetics of the QM3Glu-Trip with the substrate BApNA were demonstrated.